D-1383-2016 Class II Terminated

Recalled by Pharmedium Services, LLC — Lake Forest, IL

FDA drug recall D-1383-2016 was initiated by Pharmedium Services, LLC on May 5, 2016 and is designated Class II. Reason for recall: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs. The recall status is terminated (terminated Mar 6, 2018). Affected quantity: 55 bags.

Recall Details

Product Type
Drugs
Report Date
Jul 27, 2016
Initiation Date
May 5, 2016
Termination Date
Mar 6, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
55 bags

Product Description

10 mcg/mL HYDROmorphone HCl and 0.0625% Bupivacaine HCl in 0.9% Sodium Chloride, 250 mL in 250 mL Baxter Intravia Bag, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-733-17

Reason for Recall

Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Distribution Pattern

Nationwide

Code Information

Lot Number 160470116M , Exp. Date 5/17/2016 ; Lot Number 160490123M , Exp. Date 5/19/2016 ; Lot Number 160800048M , Exp. Date 6/18/2016 ; Lot Number 160890060M , Exp. Date 6/27/2016 ; Lot Number 160940050M , Exp. Date 7/2/2016 ;

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1383-2016
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.